Hester Biosciences Limited (HESTERBIO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs174.78 Million ≈ $1.89 Million USD) by net assets (Rs3.51 Billion ≈ $37.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hester Biosciences Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Hester Biosciences Limited debt and liabilities for a breakdown of total debt and financial obligations.

Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arrowmark Financial Corp NASDAQ:BANX	0.016x
Westwood Holdings Group Inc NYSE:WHG	0.068x
Naturhouse Health SA MC:NTH	0.154x
Lotus Resources Ltd AU:LOT	0.006x
PT MNC Energy Investments Tbk JK:IATA	0.015x
Wanhwa Enterprise Co TW:2701	0.006x
Reit Azorim HF Living Ltd TA:AZRT	0.010x
Dune Acquisition Corporation II Class A Ordinary Shares NASDAQ:IPOD	0.000x

Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Hester Biosciences Limited stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs3.27 Billion ≈ $35.33 Million	Rs645.11 Million ≈ $6.98 Million	0.197x	+24.27%
2024-03-31	Rs3.03 Billion ≈ $32.75 Million	Rs481.34 Million ≈ $5.21 Million	0.159x	+96.92%
2023-03-31	Rs2.92 Billion ≈ $31.62 Million	Rs235.96 Million ≈ $2.55 Million	0.081x	+145.00%
2022-03-31	Rs2.67 Billion ≈ $28.92 Million	Rs88.08 Million ≈ $952.55K	0.033x	-86.61%
2021-03-31	Rs2.36 Billion ≈ $25.52 Million	Rs580.53 Million ≈ $6.28 Million	0.246x	+32.67%
2020-03-31	Rs2.06 Billion ≈ $22.33 Million	Rs382.92 Million ≈ $4.14 Million	0.185x	-30.32%
2019-03-31	Rs1.81 Billion ≈ $19.59 Million	Rs482.10 Million ≈ $5.21 Million	0.266x	+1.48%
2018-03-31	Rs1.45 Billion ≈ $15.68 Million	Rs380.24 Million ≈ $4.11 Million	0.262x	-6.41%
2017-03-31	Rs1.24 Billion ≈ $13.43 Million	Rs347.98 Million ≈ $3.76 Million	0.280x	+51.04%
2016-03-31	Rs1.05 Billion ≈ $11.34 Million	Rs194.44 Million ≈ $2.10 Million	0.186x	-34.69%
2015-03-31	Rs838.58 Million ≈ $9.07 Million	Rs238.21 Million ≈ $2.58 Million	0.284x	+129.46%
2014-03-31	Rs762.88 Million ≈ $8.25 Million	Rs94.44 Million ≈ $1.02 Million	0.124x	-26.51%
2013-03-31	Rs684.95 Million ≈ $7.41 Million	Rs115.37 Million ≈ $1.25 Million	0.168x	-27.37%
2012-03-31	Rs610.60 Million ≈ $6.60 Million	Rs141.61 Million ≈ $1.53 Million	0.232x	-14.56%
2011-03-31	Rs479.85 Million ≈ $5.19 Million	Rs130.26 Million ≈ $1.41 Million	0.271x	-18.64%
2010-03-31	Rs408.64 Million ≈ $4.42 Million	Rs136.33 Million ≈ $1.47 Million	0.334x	+57.34%
2009-03-31	Rs366.47 Million ≈ $3.96 Million	Rs77.71 Million ≈ $840.36K	0.212x	-27.97%
2008-03-31	Rs334.69 Million ≈ $3.62 Million	Rs98.53 Million ≈ $1.07 Million	0.294x	-30.04%
2007-03-31	Rs279.47 Million ≈ $3.02 Million	Rs117.60 Million ≈ $1.27 Million	0.421x	+225.91%
2006-03-31	Rs136.48 Million ≈ $1.48 Million	Rs17.62 Million ≈ $190.56K	0.129x	--

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic

Market Cap

$150.34 Million

Rs13.90 Billion INR

Market Cap Rank

#17629 Global

#914 in India

Share Price

Rs1634.20

Change (1 day)

-1.29%

52-Week Range

Rs1259.10 - Rs2193.80

All Time High

Rs3204.96